NEW YORK (GenomeWeb News) – The National Institute of Mental Health’s Laboratory of Neurotoxicology is seeking interested parties to collaborate in a research alliance to develop and commercialize protein quantification techniques using mass spectrometry.
 
NIMH said the technology can be used in basic research, to diagnose disease, or determine amounts of specific marker proteins in heterogeneous mixtures such as blood or urine.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.